Ultra-low-pass whole genome sequencing (ULP-WGS) of circulating tumor DNA appears to provide important prognostic information regarding patients with large B-cell lymphoma (LBCL), according to ...
QIAGEN N.V. today announced the launch of the EZ2 DNA Investigator Sep&Prep Kit, a fully automated solution for processing sexual assault samples, at the upcoming International Symposium on Human ...
A novel tool could reduce the time it takes to diagnose and classify acute leukemias from days to hours through DNA ...
The global next generation sequencing (NGS) market is expected to register a robust CAGR of around 15% over the next five years. This growth is primarily driven by the rising adoption of precision ...
Key market opportunities in the AI clinical trial protocol feasibility tool sector include rising demand for personalized and ...
An artificial intelligence model predicts how brain immune cells react to RNA and DNA nanoparticles, helping scientists design safer and more effective nucleic acid therapies faster.
NeoGenomics will present research at ISLB 2025 showing high concordance between its RaDaR ST and RaDaR 1.0 MRD assays, plus ...
Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...
Ozempic, MRI machines and flat screen televisions all emerged out of fundamental research decades earlier — the very types of ...
Across conversations on precision oncology, malignant hematology, cellular therapies, and social determinants of health (SDOH ...
A team of scientists has developed a highly accurate blood test for Chronic Fatigue Syndrome. The test reads tiny DNA patterns that reveal the biological signature of the illness. For millions who’ve ...
US food tech startup The Every Company has raised $55M in Series D funding to expand its precision-fermented egg proteins, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results